Literature DB >> 191208

Seroimmunity to polioviruses in an urban population of Italy.

A Volpi, G Ragona, W Biondi, G Rocchi, I Archetti.   

Abstract

In a seroepidemiological survey on immunity to polioviruses, carried out in Rome, neutralizing antibodies were titrated on 602 serum samples collected from individuals aged from 6 months to 88 years. The geometric mean titres were 25.24, 25.92, and 18.12 for poliovirus types 1, 2, and 3, respectively. The number of seronegative results for each virus strain was very low (</=1.5%). The immune status of the study population could therefore be considered satisfactory. The distribution of antibody reactivity in different age groups was similar for poliovirus types 1 and 3, while for type 2 a significant difference in titres was found between adults and children.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 191208      PMCID: PMC2366572     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  3 in total

1.  [Seroepidemiologic research on the antipoliomyelitic immunity in adult unvaccinated subjects].

Authors:  R Trivello; M E Moschen; M Romano; V Gasparini
Journal:  Boll Ist Sieroter Milan       Date:  1975

2.  [Immunitary defense against polioviruses in various population samples in several years following Sabin vaccination].

Authors:  F L Petrilli; P Crovari; S De Flora; G Badolati; A Vannucci
Journal:  Ann Sclavo       Date:  1971 May-Jun

3.  [On the immunological situation seven years after the introduction into Italy of poliomyelitis vaccination with attenuated live virus vaccine].

Authors:  L Squeri; M L Calisto; L Sindoni; G Mattace-Raso
Journal:  Ann Sclavo       Date:  1973 Jan-Feb
  3 in total
  8 in total

1.  Antipoliomyelitis immunity status among a population that was regularly vaccinated 11-12 years before.

Authors:  E Bellelli; M L Tanzi; V Bocelli; U Bracchi; P Affanni
Journal:  Eur J Epidemiol       Date:  1991-11       Impact factor: 8.082

2.  Serum antibodies to polioviruses in a Tuscan population, Italy.

Authors:  D Reali; A Carducci; M A Ruschi
Journal:  Eur J Epidemiol       Date:  1990-09       Impact factor: 8.082

3.  Serum antibodies to poliomyelitis in Italy.

Authors:  R Santoro; F Lombardi; F Novello; C Amato; F M Ruggeri; M E Grandolfo; I Annesi; C M Cortellessa; F Timperi; R Inglese
Journal:  Bull World Health Organ       Date:  1984       Impact factor: 9.408

4.  Poliomyelitis immunity status at different intervals from vaccination.

Authors:  E Bellelli; U Bracchi; M L Tanzi; G Benaglia; G Montanarini
Journal:  Eur J Epidemiol       Date:  1986-09       Impact factor: 8.082

5.  Vaccination against poliomyelitis in economically underdeveloped countries.

Authors:  A B Sabin
Journal:  Bull World Health Organ       Date:  1980       Impact factor: 9.408

Review 6.  Is EU/EEA population protected from polio?

Authors:  Dre Nijsten; P Carrillo-Santisteve; A Miglietta; J Ruitenberg; P L Lopalco
Journal:  Hum Vaccin Immunother       Date:  2015-04-21       Impact factor: 3.452

7.  Immunogenicity of Viral Vaccines in the Italian Military.

Authors:  Claudia Ferlito; Roberto Biselli; Vincenzo Visco; Maria Sofia Cattaruzza; Maria Rosaria Capobianchi; Concetta Castilletti; Daniele Lapa; Loredana Nicoletti; Antonella Marchi; Fabio Magurano; Anna Rita Ciccaglione; Paola Chionne; Elisabetta Madonna; Isabella Donatelli; Laura Calzoletti; Concetta Fabiani; Michela Ileen Biondo; Raffaela Teloni; Sabrina Mariotti; Gerardo Salerno; Andrea Picchianti-Diamanti; Simonetta Salemi; Sara Caporuscio; Alberto Autore; Patrizia Lulli; Francesco Borelli; Marco Lastilla; Roberto Nisini; Raffaele D'Amelio
Journal:  Biomedicines       Date:  2021-01-17

8.  Serological survey on immunity status against polioviruses in children and adolescents living in a border region, Apulia (Southern Italy).

Authors:  Silvio Tafuri; Rosa Prato; Domenico Martinelli; Agata Calvario; Anna Bozzi; Michele Labianca; Annamaria Patti; Pietro Luigi Lopalco; Cinzia Germinario
Journal:  BMC Infect Dis       Date:  2008-10-30       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.